Stellate Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Stellate Therapeutics's estimated annual revenue is currently $2.3M per year.
- Stellate Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Stellate Therapeutics has 15 Employees.
- Stellate Therapeutics grew their employee count by -6% last year.
Stellate Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Stellate Therapeutics?
Stellate Therapeutics is a pre-clinical stage start-up company developing innovative microbiome-derived small molecules to treat neurodegenerative diseases. We utilize the microbiome for our drug portfolio and our research focuses on the gut-brain axis. Due to millions of years of co-evolution, complex metabolic interactions exist between humans and their gut bacteria and Stellate has uncovered a unique set of metabolites that are produced by the microbiome and are involved in the maintenance of health. Our first drug will be a treatment for Parkinson’s disease.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 15 | N/A | N/A |
#2 | $1.3M | 15 | N/A | N/A |
#3 | $2.9M | 15 | N/A | N/A |
#4 | $1.3M | 15 | N/A | N/A |
#5 | $1.3M | 15 | N/A | N/A |